FindTrial
Sign In

Scabies treatment by oral medicine

Efficacy of two doses of Ivermectin tablet in treatment of scabies in comparison to once application of 5% Permethrin lotion- A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040762
Enrollment
100
Registered
2022-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B86- Scabies

Interventions

Intervention1: Oral Ivermectin: In the intervention arm, Ivermectin tablets will be given to the participants at a dose of 200 micrograms per kg body weight on day 1 and day 7. All the family and clo

Sponsors

Dr Priyamadhaba Behera
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as a case of scabies by a physician Patients who have given written informed consent

Exclusion criteria

Exclusion criteria: Pregnant and lactating women History of allergy to Ivermectin Children age less than 5 years Seizure disorder Diagnosed case of Parkinsonism Patient treated with any topical or systemic scabicidal therapy in the month before entry Norwegian scabies

Design outcomes

Primary

MeasureTime frame
Cure rate of scabiesTimepoint: Day 28 of treatment initiation—

Secondary

MeasureTime frame
Not availableTimepoint: Not applicable—

Countries

India

Contacts

Public ContactDr Binod Kumar Patro

AIIMS, Bhubaneswar

cmfm_priyamadhaba@aiimsbhubaneswar.edu.in9910830997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026